Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Abivax shares surged 500% after positive phase 3 results for obefazimod in moderate-to-severe ulcerative colitis. Click here ...

A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...

A team of researchers testing an experimental messenger RNA (mRNA) vaccine managed to ramp up the ability of immunotherapy to combat tumors in a stu ...

A University of Florida study shows an mRNA vaccine combined with immunotherapy drugs significantly boosts the immune systems ...

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...

Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...

New research published in the Journal of Psychopharmacology has found that a single dose of psilocybin leads to widespread ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers ...